Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Journal of Experimental Medicine

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes.  217. 2020
  • Extensive dissemination and intraclonal maturation of HIV Env vaccine-induced B cell responses.  217. 2020
  • Antibody barriers to going viral.  216:2226-2228. 2019
  • Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes.  216:2331-2347. 2019
  • IL-27 promotes the expansion of self-renewing CD8+ T cells in persistent viral infection.  216:1791-1808. 2019
  • EDA fibronectin-TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis.  216:587-604. 2019
  • 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice.  216:279-293. 2019
  • Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity.  215:2617-2635. 2018
  • Genome-scale CRI SPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma.  215:2137-2155. 2018
  • A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival.  215:1839-1852. 2018
  • CDK2 inhibitors as candidate therapeutics for cisplatin-and noise-induced hearing loss.  215:1187-1203. 2018
  • Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo.  214:2573-2590. 2017
  • Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span.  214:2387-2404. 2017
  • Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.  214:2471-2490. 2017
  • Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.  213:1937-1950. 2016
  • A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells.  213:1901-1919. 2016
  • Receptor editing and genetic variability in human autoreactive B cells.  213:93. 2016
  • CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts.  212:1283-1301. 2015
  • The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function.  212:1011-1020. 2015
  • Breaking the allergic response by disrupting antibody glycosylation.  212. 2015
  • SIRT1 deacetylates RORγt and enhances Th17 cell generation.  212:607-617. 2015
  • Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.  211:2061-2074. 2014
  • Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.  210:1807-1821. 2013
  • Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies.  210:655-663. 2013
  • The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain.  210:23-30. 2013
  • ZBTB1 is a determinant of lymphoid development.  209:19-27. 2012
  • Cd1b tetramers bind alpha beta t cell receptors to identify a mycobacterial glycolipid-reactive t cell repertoire in humans.  208:1741-1747. 2011
  • Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells.  208:1875-1887. 2011
  • Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.  208:1359-1366. 2011
  • Liver-expressed Igκ superantigen induces tolerance of polyclonal B cells by clonal deletion not κ to λ receptor editing.  208:617-629. 2011
  • Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction.  207:1843-1851. 2010
  • Central nervous system (cns)-resident natural killer cells suppress th17 responses and cns autoimmune pathology.  207:1907-1921. 2010
  • The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glands.  207:1465-1474. 2010
  • Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.  207:173-187. 2010
  • Soluble hiv-1 env trimers in adjuvant elicit potent and diverse functional b cell responses in primates.  207:2003-2017. 2010
  • T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow.  206:2469-2481. 2009
  • Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci.  206:2271-2284. 2009
  • Xbp1 governs late events in plasma cell differentiation and is not required for antigen-specific memory b cell development.  206:2151-2159. 2009
  • Unc93b1 biases toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against rna-sensing.  206:1339-1350. 2009
  • A role for human skin-resident T cells in wound healing.  206:743-750. 2009
  • In vivo expansion of t reg cells with il-2-mab complexes: Induction of resistance to eae and long-term acceptance of islet allografts without immunosuppression.  206:751-760. 2009
  • Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.  206:51-59. 2009
  • ICOS-dependent extrafollicular helper T cells elicit igg production via IL-21 in systemic autoimmunity.  205:2873-2886. 2008
  • Macaques vaccinated with live-attenuated SIV control replication of heterologous virus.  205:2537-2550. 2008
  • Repertoire-based selection into the marginal zone compartment during B cell development.  205:2043-2052. 2008
  • Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells.  205:1917-1927. 2008
  • Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.  205:1409-1422. 2008
  • Il-10 blockade facilitates DNA vaccine-induced t cell responses and enhances clearance of persistent virus infection.  205:533-541. 2008
  • Increased endothelial expression of toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.  205:373-383. 2008
  • Development of all CD4 T lineages requires nuclear factor TOX.  205:245-256. 2008
  • Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.  204:3103-3111. 2007
  • Reduced receptor editing in lupus-prone MRL/1pr mice.  204:2853-2864. 2007
  • T cell activation enhancement by endogenous pMHC acts for both weak and strong agonists but varies with differentiation state.  204:2747-2757. 2007
  • Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.  204:2439-2448. 2007
  • An intense form of homeostatic proliferation of naive cd8(+) cells driven by il-2.  204:1787-1801. 2007
  • Identification of an il-17-producing nk1.1(neg) inkt cell population involved in airway neutrophilia.  204:995-1001. 2007
  • A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d.  204:921-928. 2007
  • Antiviral cd4(+) memory t cells are il-15 dependent.  204:951-961. 2007
  • Jinx, an mcmv susceptibility phenotype caused by disruption of unc13d: A mouse model of type 3 familial hemophagocytic lymphohistiocytosis.  204:853-863. 2007
  • The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells.  204:841-852. 2007
  • Adoptive immunotherapy induces cns dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection.  203:1963-1975. 2006
  • Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.  203:2033-2042. 2006
  • A major histocompatibility complex class I-dependent subset of memory phenotype CD8(+) cells.  203:1817-1825. 2006
  • Mechanisms imposing the V beta bias of V alpha 14 natural killer T cells and consequences for microbial glycolipid recognition.  203:1197-1207. 2006
  • Immune responses and HIV: A little order from the chaos.  203:501-503. 2006
  • Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity.  202:1517-1526. 2005
  • A role for dual viral hits in causation of subacute sclerosing panencephalitis.  202:1185-1190. 2005
  • Socs-1 regulates il-15-driven homeostatic proliferation of antigen-naive cd8 t cells, limiting their autoimmune potential.  202:1099-1108. 2005
  • Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific cd8(+) t cells.  202:907-912. 2005
  • Characterization of the early stages of thymic NKT cell development.  202:485-492. 2005
  • DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis.  202:363-369. 2005
  • Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes.  202:239-248. 2005
  • Many roads, one destination for T cell progenitors.  202:11-13. 2005
  • Gamma delta t cell-induced hyaluronan production by epithelial cells regulates inflammation.  201:1269-1279. 2005
  • Interferon-gamma acts directly on cd8(+) t cells to increase their abundance during virus infection.  201:1053-1059. 2005
  • An immunoglobulin Cκ-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system.  201:817-828. 2005
  • The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization.  200:1491-1501. 2004
  • Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions.  200:469-479. 2004
  • Thymic t cell development and progenitor localization depend on ccr7.  200:481-491. 2004
  • Deletion of the nucleotide excision repair gene ercc1 reduces immunoglobulin class switching and alters mutations near switch recombination junctions.  200:321-330. 2004
  • Receptor editing and marginal zone b cell development are regulated by the helix-loop-helix protein, e2a.  199:1101-1112. 2004
  • TOX provides a link between calcineurin activation and CD8 lineage commitment.  199:1089-1099. 2004
  • Deficiency of the cyclin kinase inhibitor P21(WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoirnmunity.  199:547-557. 2004
  • Interleukin 7 regulates the survival and generation of memory cd4 cells.  198:1797-1806. 2003
  • A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease.  198:1563-1572. 2003
  • Kinetics of steady-state differentiation and mapping of intrathymic-signaling environments by stem cell transplantation in nonirradiated mice.  198:957-962. 2003
  • A role of the fast ATP-gated P2X(1) cation channel in thrombosis of small arteries in vivo.  198:661-667. 2003
  • Visualization of the genesis and fate of isotype-switched b cells during a primary immune response.  197:1677-1687. 2003
  • Orphan nuclear receptor nur77 is involved in caspase-independent macrophage cell death.  197:1441-1452. 2003
  • Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.  197:777-788. 2003
  • Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.  197:777-788. 2003
  • Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction.  197:615-624. 2003
  • Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype cd8(+) t cells.  196:935-946. 2002
  • CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.  196:481-492. 2002
  • Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens.  196:323-333. 2002
  • Overexpression of interleukin (il)-7 leads to il-15-independent generation of memory phenotype cd8(+) t cells.  195:1533-1539. 2002
  • Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.  195:1175-1186. 2002
  • Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression.  195:1003-1012. 2002
  • c-Jun NH2-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.  195:801-810. 2002
  • Distinct functional lineages of human V(alpha)24 natural killer T cells.  195:637-641. 2002
  • Aging leads to disturbed homeostasis of memory phenotype cd8(+) cells.  195:283-293. 2002
  • Interleukin (il)-15 and il-7 jointly regulate homeostatic proliferation of memory phenotype cd8(+) cells but are not required for memory phenotype cd4(+) cells.  195:1523-1532. 2002
  • Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.  194:1755-1766. 2001
  • Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.  194:1661-1673. 2001
  • Determinants of viral clearance and persistence during acute hepatitis C virus infection.  194:1395-1406. 2001
  • Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.  194:707-717. 2001
  • Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells.  194:645-656. 2001
  • The role of recombination activating gene (RAG) reinduction in thymocyte development in vivo.  194:471-480. 2001
  • Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development.  194:127-134. 2001
  • Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45).  194:89-98. 2001
  • Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor.  193:1059-1065. 2001
  • Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant.  193:925-934. 2001
  • The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families.  193:893-904. 2001
  • Antigen-specific t helper cell function: Differential cytokine expression in primary and memory responses.  192:1301-1316. 2000
  • Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.  192:1249-1260. 2000
  • Genetic modulation of T cell receptor gene segment usage during somatic recombination.  192:1191-1196. 2000
  • Natural killer T cell activation inhibits hepatitis B virus replication in vivo.  192:921-930. 2000
  • Host-virus interactions during malaria infection in hepatitis B virus transgenic mice.  192:529-535. 2000
  • Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice.  192:289-294. 2000
  • In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.  191:1895-1903. 2000
  • Antigen-specific b cell memory: Expression and replenishment of a novel b220(-) memory b cell compartment.  191:1149-1165. 2000
  • Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.  191:1247-1252. 2000
  • T cells can use either t cell receptor or cd28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells.  191:1137-1148. 2000
  • Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells.  190:1227-1239. 1999
  • Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM).  190:1351-1356. 1999
  • In vivo-activated cd4 t cells upregulate cxc chemokine receptor 5 and reprogram their response to lymphoid chemokines.  190:1123-1134. 1999
  • Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature b cells.  190:749-756. 1999
  • Evolution of antigen-specific t cell receptors in vivo: Preimmune and antigen-driven selection of preferred complementarity-determining region 3 (cdr3) motifs.  189:1823-1837. 1999
  • Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.  189:1555-1564. 1999
  • A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma.  189:1101-1110. 1999
  • Effects of complementarity determining region mutations on the affinity of an alpha/beta T cell receptor: measuring the energy associated with CD4/CD8 repertoire skewing.  189:461-470. 1999
  • Positive and negative regulation of v(d)j recombination by the e2a proteins.  189:289-300. 1999
  • A T cell receptor-specific blockade of positive selection.  189:13-23. 1999
  • Molecular recognition of lipid antigens by t cell receptors.  189:195-205. 1999
  • Genetic regulation of commitment to interleukin 4 production by a cd4(+) t cell-intrinsic mechanism.  188:2289-2299. 1998
  • Antigens varying in affinity for the b cell receptor induce differential b lymphocyte responses.  188:1453-1464. 1998
  • Receptor editing occurs frequently during normal b cell development.  188:1231-1238. 1998
  • The envelope glycoprotein ectodomains determine the efficiency of cd4(+) t lymphocyte depletion in simian-human immunodeficiency virus-infected macaques.  188:1159-1171. 1998
  • The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope.  188:1017-1028. 1998
  • Efficient peripheral clonal elimination of b lymphocytes in mrl/lpr mice bearing autoantibody transgenes.  188:909-917. 1998
  • Immune pathogenesis of hepatocellular carcinoma.  188:341-350. 1998
  • A role for fas in negative selection of thymocytes in vivo.  187:1427-1438. 1998
  • Sequence of the spacer in the recombination signal sequence affects V(D)J rearrangement frequency and correlates with nonrandom V kappa usage in vivo.  187:1495-1503. 1998
  • T cell receptor (tcr)-induced death of immature cd4(+)cd8(+) thymocytes by two distinct mechanisms differing in their requirement for cd28 costimulation: Implications for negative selection in the thymus.  186:1911-1922. 1997
  • Enforced bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral b cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature b cells.  186:1513-1522. 1997
  • Inhibition of virus attachment to cd4(+) target cells is a major mechanism of t cell line-adapted hiv-1 neutralization.  186:1287-1298. 1997
  • Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection.  186:405-411. 1997
  • Identification of a thymic epithelial cell subset sharing expression of the class ib hla-g molecule with fetal trophoblasts.  186:289-298. 1997
  • CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.  185:1681-1691. 1997
  • T cell receptor (TCR)-beta gene recombination: Dissociation from cell cycle regulation and developmental progression during T cell ontogeny.  185:1549-1556. 1997
  • Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.  185:833-841. 1997
  • Induction of the early growth response (Egr) family of transcription factors during thymic selection.  185:731-744. 1997
  • Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus.  185:531-539. 1997
  • Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease.  184:2371-2384. 1996
  • B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen.  184:1685-1697. 1996
  • Cd81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation.  184:2055-2060. 1996
  • Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis.  184:765-770. 1996
  • Cell adhesion and migration are regulated at distinct stages of thymic t cell development: The roles of fibronectin, vla4, and vla5.  184:215-228. 1996
  • Antigen compartmentation and t helper cell tolerance induction.  183:2617-2626. 1996
  • Cd40l-deficient mice show deficits in antiviral immunity and have an impaired memory cd8(+) ctl response.  183:2129-2142. 1996
  • Regulation of cell division cycle progression by bcl-2 expression: A potential mechanism for inhibition of programmed cell death.  183:2219-2226. 1996
  • Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules.  183:2087-2095. 1996
  • T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy.  183:2361-2366. 1996
  • Bone marrow-derived cells fail to induce positive selection in thymus reaggregation cultures.  183:1235-1240. 1996
  • Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.  183:473-484. 1996
  • Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice.  183:311-316. 1996
  • Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.  182:1201-1212. 1995
  • Human CD8 transgene regulation of HLA recognition by murine T cells.  182:1315-1325. 1995
  • Thymic selection and cell-division.  182:961-971. 1995
  • Viral interleukin-10 (IL-10), the human herpes-virus-4 cellular IL-10 homolog, induces local anergy to allogeneic and syngeneic tumors.  182:477-486. 1995
  • T cell receptor gene recombination patterns and mechanisms: cell death, rescue, and T cell production.  182:121-127. 1995
  • Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide.  181:857-866. 1995
  • The cytotoxic T-lymphocyte response to multiple hepatitis-B virus polymerase epitopes during and after acute viral-hepatitis.  181:1047-1058. 1995
  • Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.  181:735-745. 1995
  • Up-regulation of surface-markers on dying thymocytes.  181:649-655. 1995
  • Thymic selection and adaptability of cytotoxic t-lymphocyte responses in transgenic mice expressing a viral protein in the thymus.  180:1901-1910. 1994
  • Cytotoxic T-lymphocyte response to a wild-type hepatitis-B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.  180:933-943. 1994
  • Profound atrophy of the bone-marrow reflecting major histocompatibility complex class ii-restricted destruction of stem-cells by cd4+ cells.  180:307-317. 1994
  • Constitutive activation of integrin alpha 4 beta 1 defines a unique stage of human thymocyte development.  179:1573-1584. 1994
  • Interferon gamma receptor deficient mice are resistant to endotoxic shock.  179:1437-1444. 1994
  • Autoimmunity and apoptosis.  179:1083-1086. 1994
  • Transforming growth-factor-beta as endogenous growth inhibitor of chronic lymphocytic-leukemia B-cells.  179:999-1004. 1994
  • Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.  179:213-219. 1994
  • Rat t-cell response to superantigens .1. V-beta-restricted clonal deletion of rat t-cells differentiating in rat - mouse chimeras.  179:57-62. 1994
  • Rat t-cell responses to superantigens .2. Allelic differences in v-beta-8.2 and v-beta-8.5 beta-chains determine responsiveness to staphylococcal-enterotoxin-b and mouse mammary-tumor virus-encoded products.  179:63-69. 1994
  • A critical role for monocytes and cd14 in endotoxin-induced endothelial-cell activation.  178:2193-2200. 1993
  • Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human rantes but not human monocyte chemoattractant protein-1, human macrophage inflammatory protein 1-alpha, or human interleukin-8.  178:1913-1921. 1993
  • Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA.  178:2047-2053. 1993
  • Mechanisms of class-I restricted immunopathology - A transgenic mouse model of fulminant-hepatitis.  178:1541-1554. 1993
  • Autoimmune diabetes can be induced in transgenic major histocompatibility complex class-ii-deficient mice.  178:589-596. 1993
  • Multiple rearrangements in T-cell receptor alpha-chain genes maximize the production of useful thymocytes.  178:615-622. 1993
  • Protective effects of sialylated oligosaccharides in immune-complex induced acute lung injury.  178:623-631. 1993
  • Bacterial superantigens mediate T-cell deletions in the mouse severe combined immunodeficiency human liver thymus model.  177:1481-1485. 1993
  • Extinction of the tumor-necrosis-factor locus, and of genes encoding the lipopolysaccharide signaling pathway.  177:1383-1390. 1993
  • Receptor editing in self-reactive bone-marrow b-cells.  177:1009-1020. 1993
  • Characterization and species distribution of high-affinity gtp-coupled receptors for human rantes and monocyte chemoattractant protein-1.  177:851-856. 1993
  • HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.  177:751-762. 1993
  • Exclusion of circulating t-cells from the thymus does not apply in the neonatal-period.  177:379-385. 1993
  • Antigen-driven B cell differentiation in vivo.  178:295-307. 1993
  • Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation.  177:191-194. 1993
  • Thymic selection of the human T-cell receptor V-beta repertoire in SCID-HU mice.  176:1619-1624. 1992
  • Growth of epithelial-cells in the thymic medulla is under the control of mature t-cells.  176:611-616. 1992
  • Lipopolysaccharide (lps) partial structures inhibit responses to lps in a human macrophage cell-line without inhibiting lps uptake by a cd14-mediated pathway.  176:485-494. 1992
  • Bcl2 oncogene translocation is mediated by a chi-like consensus.  175:1575-1588. 1992
  • Transfection of cd14 into 70z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (lps) and lps binding-protein.  175:1697-1705. 1992
  • Extracellular processing of peptide antigens that bind class I major histocompatibility molecules.  175:1221-1226. 1992
  • Thymus-grafted scid mice show transient thymopoiesis and limited depletion of v-beta-11+ t-cells.  175:1067-1071. 1992
  • Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo.  176:1291-1302. 1992
  • Two subsets of epithelial cells in the thymic medulla.  176:495-505. 1992
  • A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.  174:1483-1489. 1991
  • Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.  174:1565-1570. 1991
  • Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in thp-1 monocytic cells requires both activator protein-1 and nuclear factor-kappa-b binding-sites.  174:1517-1526. 1991
  • Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor.  174:1239-1244. 1991
  • Mature murine-b and t-cells transferred to scid mice can survive indefinitely and many maintain a virgin phenotype.  174:717-728. 1991
  • T cell contact with Ia antigens on nonhemopoietic cells in vivo can lead to immunity rather than tolerance.  174:435-446. 1991
  • Infection of lymphocytes by a virus that aborts cytotoxic lymphocyte-t activity and establishes persistent infection.  174:203-212. 1991
  • Junctional sequences of fetal T-cell receptor-beta chains have few N-regions.  174:115-124. 1991
  • Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin.  173:1407-1419. 1991
  • Reentry of t-cells to the adult thymus is restricted to activated t-cells.  173:1039-1046. 1991
  • Tumor suppression after tumor-cell targeted tumor-necrosis-factor-alpha gene-transfer.  173:1047-1052. 1991
  • Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.  173:1007-1015. 1991
  • Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex.  173:941-952. 1991
  • Adoptive transfer of neonatal T lymphocytes rescues immunoglobulin production in mice with severe combined immune deficiency.  173:265-268. 1991
  • Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro.  172:1583-1588. 1990
  • Lack of N-regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences.  172:1377-1390. 1990
  • Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products.  172:419-429. 1990
  • The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells.  172:475-485. 1990
  • Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin tumor-necrosis-factor synthesis at separate points in the signaling pathway.  172:391-394. 1990
  • Viruses as therapeutic agents .1. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes-mellitus while maintaining general immune competence.  171:2077-2089. 1990
  • Viruses as therapeutic agents .2. Viral reassortants map prevention of insulin-dependent diabetes-mellitus to the small rna of lymphocytic choriomeningitis virus.  171:2091-2100. 1990
  • Endotoxin-responsive sequences control cachectin tumor necrosis factor biosynthesis at the translational level.  171:465-475. 1990
  • Tolerance-related v-beta clonal deletions in normal cd4-8-, tcr-alpha/beta+ and abnormal lpr and gld cell-populations.  170:1869-1877. 1989
  • Lipopolysaccharide (lps) binding-protein opsonizes lps-bearing particles for recognition by a novel receptor on macrophages.  170:1231-1241. 1989
  • Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response.  170:1091-1101. 1989
  • Class-i mhc can present an endogenous peptide to cyto-toxic lymphocytes-t.  170:1033-1038. 1989
  • Exacerbation of murine listeriosis by a monoclonal-antibody specific for the type-3 complement receptor of myelomonocytic cells - absence of monocytes at infective foci allows listeria to multiply in nonphagocytic cells.  170:27-37. 1989
  • Interleukin-3 (il-3) induces transcription from nonrearranged t-cell receptor gamma loci in il-3-dependent cell-lines.  169:2059-2071. 1989
  • Peptide-specific prevention of experimental allergic encephalomyelitis - neonatal tolerance induced to the dominant T-cell determinant of myelin basic-protein.  169:1681-1691. 1989
  • Antibody to the murine type 3 complement receptor inhibits T lymphocyte-dependent recruitment of myelomonocytic cells in vivo.  169:535-548. 1989
  • In vivo expression of perforin by CD8+ lymphocytes during an acute viral infection.  169:2159-2171. 1989
  • Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA.  169:351-356. 1989
  • Epstein-barr virus regulates activation and processing of the 3rd component of complement.  168:949-969. 1988
  • CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS).  168:623-635. 1988
  • Fine dissection of a 9 amino-acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class-i-restricted h-2db cyto-toxic lymphocytes-t.  168:559-570. 1988
  • Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.  168:213-227. 1988
  • A 52-kD protein is a novel component of the SS-A/Ro antigenic particle.  167:1560-1571. 1988
  • Organ-specific selection of viral variants during chronic infection.  167:1719-1724. 1988
  • B-cell stimulating factor-2/interleukin-6 is a costimulant for human thymocytes and lymphocytes-T.  167:1253-1258. 1988
  • Cachectin tumor necrosis factor induces cachexia, anemia, and inflammation.  167:1211-1227. 1988
  • Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties.  167:570-581. 1988
  • Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies.  166:1627-1640. 1987
  • Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.  166:1685-1701. 1987
  • Autoantibodies to hla b27 in the sera of hla b27 patients with ankylosing-spondylitis and reiters-syndrome - molecular mimicry with klebsiella-pneumoniae as potential mechanism of autoimmune-disease.  166:173-181. 1987
  • Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS).  165:1737-1742. 1987
  • Variable region sequences of murine igm anti-igg monoclonal autoantibodies (rheumatoid factors) .2. Comparison of hybridomas derived by lipopolysaccharide stimulation and secondary protein immunization.  165:970-987. 1987
  • Effect of gamma-interferon on cachectin expression by mononuclear phagocytes - reversal of the lpsd (endotoxin resistance) phenotype.  164:1791-1796. 1986
  • Cachectin tumor-necrosis-factor mediates changes of skeletal-muscle plasma-membrane potential.  164:1368-1373. 1986
  • Peptides as antigens - importance of orientation.  164:1344-1349. 1986
  • Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.  164:777-793. 1986
  • Nonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide.  164:532-547. 1986
  • Variable region sequences of murine igm anti-igg monoclonal autoantibodies (rheumatoid factors) - a structural explanation for the high-frequency of igm anti-igg b-cells.  164:407-427. 1986
  • Expression of t-cell receptor genes in an antigen-specific hybridoma and radiation-induced variants.  164:113-130. 1986
  • Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.  163:1433-1450. 1986
  • Viruses disrupt functions of human-lymphocytes .2. Measles-virus suppresses antibody-production by acting on lymphocytes-b.  163:1331-1336. 1986
  • Delineation of a defect in t-cell receptor beta-genes of nzw mice predisposed to autoimmunity.  163:644-653. 1986
  • Lack of relationship between serum gp70 levels and the severity of systemic lupus-erythematosus in mrl/1 mice.  163:458-462. 1986
  • Association of lpr gene with graft-vs-host disease like syndrome.  162:1-18. 1985
  • Cachectin tumor necrosis factor stimulates collagenase and prostaglandin-e2 production by human synovial-cells and dermal fibroblasts.  162:2163-2168. 1985
  • Eradication of established human-melanoma tumors in nude-mice by antibody-directed effector-cells.  161:1315-1325. 1985
  • Genetic elements used for a murine lupus anti-DNA autoantibody are closely related to those for antibodies to exogenous antigens.  161:805-815. 1985
  • Ig heavy-chain variable region gene-complex of lupus mice exhibits normal restriction fragment length polymorphism.  162:346-351. 1985
  • Immune-complexes can trigger specific, t-cell-dependent, autoanti-igg antibody-production in mice.  161:242-256. 1985
  • Induction of severe autoimmune-disease in normal mice by simultaneous action of multiple immunostimulators.  161:423-428. 1985
  • Purification of cachectin, a lipoprotein-lipase suppressing hormone secreted by endotoxin-induced raw 264.7 cells.  161:984-995. 1985
  • Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.  161:766-784. 1985
  • Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies.  159:1796-1801. 1984
  • Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera.  159:981-992. 1984
  • Chemical synthesis of idiotopes - evidence that antisera to the same jh1 peptide detect multiple binding site-associated idiotopes.  159:1338-1350. 1984
  • Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.  159:41-56. 1984
  • Interaction of helper T cells and Lyb5+ B cells responding to phosphorylcholine is MHC-restricted.  160:329-334. 1984
  • Monocytes can be induced by lipopolysaccharide-triggered lymphocytes-t to express functional factor vii/viia protease activity.  159:1042-1057. 1984
  • Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.  159:1429-1440. 1984
  • Negative selection in vivo reveals expression of strong Mls determinants in mice with X-linked immunodeficiency.  160:108-115. 1984
  • Selection of genetic-variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice - role in suppression of cyto-toxic lymphocyte-t response and viral persistence.  160:521-540. 1984
  • Viruses disrupt functions of human-lymphocytes - effects of measles-virus and influenza-virus on lymphocyte-mediated killing and antibody-production.  159:1322-1337. 1984
  • Allogeneic induction of the human t-cell-instructed monocyte procoagulant response is rapid and is elicited by hla-dr.  158:962-975. 1983
  • Antibody directed to determinants of a moloney virus derived mcf-gp70 recognizes a thymic differentiation antigen.  158:1751-1756. 1983
  • B-cell dependence on and response to accessory signals in murine lupus strains.  157:1815-1827. 1983
  • Cyclical antiidiotypic response to anti-hormone antibodies due to neutralization by autologous anti-antiidiotype antibodies that bind hormone.  157:1369-1378. 1983
  • Identification of a b-cell differentiation factor(s) spontaneously produced by proliferating t-cells in murine lupus strains of the lpr-lpr genotype.  157:730-742. 1983
  • Induction of murine autoimmune-disease by chronic polyclonal b-cell activation.  157:874-883. 1983
  • Induction of rheumatoid antibodies in the mouse - regulated production of autoantibody in the secondary humoral response.  158:529-545. 1983
  • Monoclonal igm rheumatoid factors derived from arthritic mrl mp-lpr lpr mice.  158:901-919. 1983
  • A recurrent idiotype on monoclonal anti-human ia antibodies.  156:1551-1556. 1982
  • A spontaneous rheumatoid arthritis-like disease in mrl/1 mice.  155:1690-1701. 1982
  • Chromosomal location of a human alpha-interferon gene family.  155:1019-1024. 1982
  • Genetic linkage of the cytolytic T lymphocyte repertoire and immunoglobulin heavy chain genes.  156:294-299. 1982
  • Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes.  155:380-389. 1982
  • Localization at high-resolution of antibody-induced mobilization of vaccinia virus hemagglutinin and the major histocompatibility antigens on the plasma-membrane of infected-cells.  156:1435-1447. 1982
  • Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune-complexes is a monocyte prothrombinase.  155:1464-1479. 1982
  • Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells.  155:403-414. 1982
  • A nuclear antigen associated with cell proliferation and blast transformation.  154:1899-1909. 1981
  • Analysis of t-cell function in autoimmune murine strains - defects in production of and responsiveness to interleukin-2.  154:791-808. 1981
  • Antigen-specific helper T cells required for dominant idiotype expression are not H-2 restricted.  154:411-421. 1981
  • Cytomegalovirus causes a latent infection in undifferentiated cells and is activated by induction of cell-differentiation.  154:1636-1651. 1981
  • Failure to cleave measles-virus fusion protein in lymphoid-cells - a possible mechanism for viral persistence in lymphocytes.  154:1489-1499. 1981
  • Identification of retroviral gp70 and anti-gp70 antibodies involved in circulating immune-complexes in nzbxnzw mice.  153:1151-1160. 1981
  • Immune complex-induced human monocyte procoagulant activity .1. A rapid unidirectional lymphocyte-instructed pathway.  154:892-906. 1981
  • In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon.  154:840-855. 1981
  • Induction of monocyte procoagulant activity by murine hepatitis-virus type-3 parallels disease susceptibility in mice.  154:1150-1163. 1981
  • Influence of thymic genotype on the systemic lupus erythematosus-like disease and t-cell proliferation of mrl-mp-lpr-lpr mice.  153:1405-1414. 1981
  • Mouse hepatitis-virus type-4 (jhm strain)-induced fatal central nervous-system disease .1. Genetic-control and the murine neuron as the susceptible site of disease.  153:832-843. 1981
  • Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.  152:742-747. 1980
  • Dissection of the B10.D2 anti-H-2Kb cytolytic T lymphocyte receptor repertoire.  151:1386-1397. 1980
  • Dissemination of contact activation in plasma by plasma kallikrein.  152:608-619. 1980
  • Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype.  151:1514-1527. 1980
  • Expression of leukemogenic recobinant viruses associated with a recessive gene in hrs-j mice.  152:249-264. 1980
  • Lymphocyte cooperation is required for amplification of macrophage procoagulant activity.  151:1232-1244. 1980
  • Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.  151:446-466. 1980
  • Association of circulating retroviral gp70-anti-gp70 immune-complexes with murine systemic lupus-erythematosus.  149:1099-1116. 1979
  • Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes.  149:516-534. 1979
  • Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.  150:445-454. 1979
  • Mice whose B cells cannot produce the T15 idiotype also lack an antigen-specific helper T cell required for T15 expression.  150:1399-1409. 1979
  • Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens.  149:495-506. 1979
  • The autoactivation of rabbit Hageman factor.  150:1122-1133. 1979
  • Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response.  147:814-829. 1978
  • Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes.  148:1628-1643. 1978
  • Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice.  148:1216-1227. 1978
  • Genetic studies of auto-immunity and retrovirus expression in crosses of new-zealand black mice .2. Viral envelope glycoprotein gp70.  147:872-881. 1978
  • Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis.  147:1018-1027. 1978
  • Presence of anti-Sm reactivity in autoimmune mouse strains.  147:582-587. 1978
  • Role of complement in pathogenesis of experimental autoimmune myasthenia gravis.  147:973-983. 1978
  • Spontaneous murine lupus-like syndromes - clinical and immunopathological manifestations in several strains.  148:1198-1215. 1978
  • Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.  147:719-729. 1978
  • The induction of secondary cytolytic T lymphocytes by solubilized membrane proteins.  147:946-951. 1978
  • DNA-binding property of Sm nuclear antigen.  145:749-754. 1977
  • Human histocompatibility determinants and virus-antigens - effect of measles-virus infection on hla expression.  146:146-156. 1977
  • Immune-response in humans after vaccination with vaccinia virus - generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.  146:949-969. 1977
  • Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers.  146:1138-1142. 1977
  • Inhibition of immunological injury of cultured-cells infected with lymphocytic choriomeningitis virus - role of defective interfering virus in regulating viral antigenic expression.  145:1449-1468. 1977
  • Isolation by cell-column chromatography of immunoglobulins specific for cell-surface carbohydrates.  145:443-449. 1977
  • Joint recognition by cytotoxic t cells of inactivated sendai virus and products of major histocompatibility complex.  145:523-539. 1977
  • Ly phenotype and mechanism of action of mouse neonatal suppressor T cells.  146:59-73. 1977
  • Specific antigen-binding cell-populations of individual fetal mouse spleens - repertoire composition, size, and genetic-control.  146:394-411. 1977
  • Synthesis and distribution of h-2 antigens in preimplantation mouse embryos.  146:923-932. 1977
  • The role of surface IgD in the response to thymic-independent antigens.  146:1707-1718. 1977
  • Analysis of stimulation-inhibition paradox exhibited by lymphocytes exposed to concanavalin-a.  144:1494-1508. 1976
  • Binding of components of properdin system to cultured human lymphoblastoid cells and b-lymphocytes.  143:271-289. 1976
  • Endogenous oncornaviral gene-expression in adult and fetal mice - quantitative, histologic, and physiologic studies of major viral glycoprotein, gp70.  143:151-166. 1976
  • Lymphocyte-activation by monovalent fragments of antibodies reactive with cell-surface carbohydrates.  143:665-671. 1976
  • Lysis of rna tumor-viruses by human-serum - direct antibody-independent triggering of classical complement pathway.  144:970-984. 1976
  • Mechanism of injury of virus-infected cells by antiviral antibody and complement - participation of igg, f(ab')2, and alternative complement pathway.  143:1027-1041. 1976
  • Participation of h-2 antigens of tumor-cells in their lysis by syngeneic t cells.  143:601-614. 1976
  • Variation and control of specific antigen-binding cell-populations in individual fetal mice.  144:259-265. 1976
  • C3-mediated cytoadherence - formation of c3 receptor aggregates as prerequisite for cell attachment.  142:242-247. 1975
  • Frequency and avidity of specific antigen-binding cells in developing mice.  142:1078-1091. 1975
  • Immunological injury in measles-virus infection .2. Suppression of immune injury through antigenic modulation.  142:864-876. 1975
  • Immunological injury of cultured-cells infected with measles-virus.  141:761-774. 1975
  • Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein.  142:1092-1107. 1975
  • Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement.  142:1570-1590. 1975
  • Oncornavirus glycoprotein gp69-71 - constituent of surface of normal and malignant thymocytes.  141:172-187. 1975
  • Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes.  141:216-226. 1975
  • Pathogenesis of cytomegalovirus-infection .1. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.  141:561-572. 1975
  • Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for igg fc and complement and description of the binding mechanism.  140:877-894. 1974
  • Binding of soluble immune complexes to human lymphoblastoid cells. Ii. Use of raji cells to detect circulating immune complexes in animal and human sera.  140:1230-1244. 1974
  • Cellular requirements for the primary in vitro antibody response to DNP-ficoll.  139:1354-1360. 1974
  • Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).  140:797-811. 1974
  • Formation and biologic role of polyoma virus-antibody complexes - critical role for complement.  140:549-565. 1974
  • Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP.  140:1122-1126. 1974
  • IgM-producing tumors in the BALB-c mouse: A model for B-cell maturation.  140:742-763. 1974
  • Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (balb-c times nzb)f1 mice by scripps leukemia virus.  140:1028-1048. 1974
  • Interstitial immune-complex thyroiditis in mice - role of autoantibody to thyroglobulin.  140:1439-1456. 1974
  • Maturation of humoral immune-response in mice.  139:249-263. 1974
  • Receptor for soluble c3 and c3b on human lymphoblastoid (raji) cells. Properties and biologocal significance.  139:696-711. 1974
  • Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement binding.  140:578-590. 1974
  • Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.  138:1564-1583. 1973
  • An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.  137:85-111. 1973
  • An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.  137:112-126. 1973
  • Characterization of splenic lymphoid cells in fetal and newborn mice.  138:557-573. 1973
  • Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities.  138:1015-1020. 1973
  • Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration.  138:1056-1064. 1973
  • Histocompatibility-linked genetic-control of disease susceptibility - murine lymphocytic choriomeningitis virus-infection.  137:1201-1212. 1973
  • Interaction of histocompatibility (hl-a) antibodies and complement with synchronized human lymphoid cells in continuous culture.  137:55-68. 1973
  • Serologic evidence for antigens controlled by ir region in mice.  138:1003-1008. 1973
  • Synthesis, assembly, and secretion of gamma-globulin by mouse myeloma cells . VI. Assembly of IGM proteins.  138:278-288. 1973
  • Thymus-dependent lymphocytes in tissue sections of rejecting rat renal-allografts.  138:1584-1590. 1973
  • Disease accompanying in utero viral infection. The role of maternal antibody in tissue injury after transplacental infection with lymphocytic choriomeningitis virus.  135:827-838. 1972
  • Functional maturation of thymic lymphocyte populations in vitro.  136:1484-1500. 1972
  • Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.  136:1356-1377. 1972
  • Plasma prekallikrein: Isolation, characterization, and mechanism of activation.  135:1-20. 1972
  • Production of macrophage migration inhibition factor by continuous cell lines.  135:255-266. 1972
  • Synthesis of plasma membrane-associated and secretory immunoglobulin in diploid lymphocytes.  135:136-149. 1972
  • Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets.  133:554-571. 1971
  • Immune complex disease in chronic viral infections.  134:32-40. 1971
  • Intrahepatic expression of serum hepatitis virus-associated antigens.  134:871-885. 1971
  • Mechanisms involved in the deposition of immune complexes in tissues.  134:75-89. 1971
  • Pathogenesis of immune complex glomerulonephritis of new zealand mice.  134:65-71. 1971
  • The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman factor).  134:986-1004. 1971
  • Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. Ii. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease.  131:1-19. 1970
  • The effect of induced chronic viral infections on the immunologic diseases of new zealand mice.  132:89-109. 1970
  • Cell interactions in the primary immune response in vitro: A requirement for specific cell clusters.  129:351-362. 1969
  • Immunological induction of increased vascular permeability. I. A rabbit passive cutaneous anaphylactic reaction requiring complement, platelets, and neutrophils.  129:153-165. 1969
  • Immunological induction of increased vascular permeability. Ii. Two mechanisms of histamine release from rabbit platelets involving complement.  129:167-184. 1969
  • Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.  129:1109-1130. 1969
  • Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice.  129:483-505. 1969
  • The anamnestic antibody response to type 3 specific pneumococcal polysaccharide.  130:77-89. 1969
  • Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen.  127:555-572. 1968
  • Autologous immune complex nephritis induced with reneal tubular antigen. II. The pathogenetic mechanism.  127:573-588. 1968
  • Isolation and characterization of permeability factors from rabbit neutrophils.  128:605-622. 1968
  • Phylogenetic origins of antibody structure .Iii. Antibodies in the primary immune response of the sea lamprey, petromyzon marinus.  127:891-914. 1968
  • Studies on circulating immune complexes. III. Factors governing the ability of circulating complexes to localize in blood vessels.  127:137-154. 1968
  • The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.  127:371-386. 1968
  • The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces.  127:119-136. 1968
  • The rate of division of antibody-forming cells during the early primary immune response.  127:983-1002. 1968
  • The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis.  126:989-1004. 1967
  • Phylogenetic origins of antibody structure. Ii. Immunoglobulins in the primary immune response of the bullfrog, rana catesbiana.  124:901-913. 1966
  • Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro.  124:733-752. 1966
  • Transfer of ovine experimental allergic glomerulonephritis (eag) with serum.  124:431-442. 1966
  • A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis.  122:99-116. 1965
  • Bound complement and immunologic injury of blood vessels.  121:215-234. 1965
  • Characteristics of an immune system common to certain external secretions.  121:101-124. 1965
  • Corroboration of recent models of γG immunoglobulin molecule.  121:373-393. 1965
  • Pathogenic factors in vascular lesions of experimental serum sickness.  122:83-98. 1965
  • Phylogenetic origins of antibody structure. I. Multichain structure of immunoglobulins in the smooth dogfish (Mustelus canis).  122:601-618. 1965
  • The role of serum complement in chemotaxis of leukocytes in vitro.  122:327-346. 1965
  • Protein-protein interactions among L polypeptide chains of Bence-Jones proteins and human gamma-globulins.  119:817-836. 1964
  • Reconstitution of 7S molecules from L and H polypeptide chains of antibodies and gamma-globulins.  119:789-815. 1964
  • Reconstitution of antiphage antibodies from L and H polypeptide chains and the formation of interspecies molecular hybrids.  120:349-358. 1964
  • Studies on human antibodies. I. Starch gel electrophoresis of the dissociated polypeptide chains.  119:443-452. 1964
  • Comparisons of Bence-Jones proteins and L polypeptide chains of myeloma globulins after hydrolysis with trypsin.  118:41-53. 1963
  • Structure and specificity of guinea pig 7S antibodies.  118:229-244. 1963
  • Studies on the localization of circulating antigen-antibody complexes and other macromolecules in vessels. I. Structural studies.  118:489-502. 1963
  • Studies on the localization of circulating antigen-antibody complexes and other macromolecules in vessels. II. Pathogenetic and pharmacodynamic studies.  118:503-513. 1963
  • The antigenic structure of the polypeptide chains of human gamma-globulin.  116:635-651. 1962
  • The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins.  116:207-227. 1962
  • Studies on structural units of the gamma-globulins.  113:861-884. 1961
  • Immunological studies of human gamma-globulin. Relation of the precipitin lines of whole gamma-globulin to those of the fragments produced by papain.  112:203-223. 1960
  • Depletion of reserve protein from extravascular extracellular fluid: C14 labeling of plasma proteins in dogs after plasmapheresis.  109:165-171. 1959
  • The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis.  110:481-494. 1959
  • Interaction of the rheumatoid factor with antigen-antibody complexes and aggregated gamma-globulin.  108:105-120. 1958
  • The cutaneous reaction to soluble antigen-antibody complexes: a comparison with the Arthus phenomenon.  108:591-604. 1958
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0022-1007

Electronic International Standard Serial Number (EISSN)

  • 1540-9538

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support